CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 4 Open-market sale Director sold 10,000 shares at $8.13 ($81,345)
- DEFA14A Proxy Proxy Materials
- 4 Open-market sale Chief Financial Officer sold 31,000 shares at $7.00 ($217,000)
- 4 Open-market sale Director sold 68,185 shares at $8.86 ($604,119)
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 30,558 shares at an average $10.97 ($335,217)
- 4 Open-market sale Director sold 10,000 shares at $10.00 ($100,000)
- 8-K Event Material agreement
- 4 Open-market sale Director sold 7,191 shares at $8.82 ($63,417)
- 4 Open-market sale Director sold 33,500 shares at an average $8.20 ($274,755)
- 8-K Event Other events
- 4 Open-market sale Chief Financial Officer sold 31,000 shares at $8.18 ($253,673)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Results of operations
Page 20 of 45 · 895 filings